Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05326633 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors
A Early Phase 1 study, sponsored by University of Maryland, Baltimore.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 78
- Enrollment target
NCT05326633 is a Early Phase 1 study that has not yet begun recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 78 participants.
The verdict
NCT05326633, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Maryland, Baltimore.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 78 participants
- Enrollment target
Study Summary
Older ICU survivors with ICU acquired weakness (ICUAW) are malnourished, sarcopenic, and functionally debilitated as a consequence of the high burden of comorbidities common in the elderly. To address the sequalae of critical illnesses, the investigators will perform a trial incorporating an intervention that combines mobility-based physical rehabilitation (MRP), high protein supplementation (HPRO), and neuromuscular electric stimulation (NMES). The investigators will then assess both clinical and functional outcomes and determine the relationship of disability with systemic inflammation.
Interventions
- COMBINATION_PRODUCT MRP and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2027-03-01 |
| Est. Completion | 2029-10-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05326633
The ClinicalTrials.gov registry entry for NCT05326633 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRP and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES) is the first listed.
NCT05326633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05326633 about?
NCT05326633 is a clinical study titled "Effect of Protein, Mobility Therapy and Electric Stimulation on Recovery in Older ICU Survivors". Older ICU survivors with ICU acquired weakness (ICUAW) are malnourished, sarcopenic, and functionally debilitated as a consequence of the high burden of comorbidities common in the elderly. To address the sequalae of critical illnesses, the investigators will perform a trial incorporating an interve...
What is the current status of trial NCT05326633?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 78 participants. The study started on 2027-03-01. Estimated completion is 2029-10-30.
What interventions are being tested in trial NCT05326633?
The interventions under investigation include: MRP and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES) (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT05326633?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.